Utilizing a measured approach can increase the probability for identifying search criteria that fulfill a company’s strategy.
Ranan Lachman
Advertisement
Articles by Ranan Lachman
Out-licensing has become a crucial part of most biotech companies' business strategies.
Companies should dig in a more attractive mine where very few other companies are looking.
Advertisement
Latest Updated Articles
Private Industry's Most EligibleOctober 1st 2004
The Art and Process of Successful In-LicensingJune 1st 2005
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
3
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
4
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
5